RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share
RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.